Dave Corney, PhD
Principal Scientist, Azenta
Dave Corney is a principal scientist within the process development team at Azenta Life Sciences. He earned his PhD in 2010 in environmental toxicology from Cornell University, where he described miR-34 downregulation following p53 inactivation and its role in tumorigenesis. He completed postdoctoral fellowships at Stanford University and Princeton University, where he employed various genomic approaches to study cancer stem cells. From April 2014 to July 2016, he served as the clinical research program manager at Thomas Jefferson University, where he designed, tested, and implemented next-generation sequencing and other genomic profiling technologies. For the past five years, Corney has evaluated emerging technologies in genomics at Azenta and spearheaded the development and commercialization of Azenta’s 10x Genomics single cell sequencing services.